$ALLR Something to consider with NFA…. 03/02/26 $2OM 💰 NON-convert/NON-dilute financing is precisely structured to bridge the current Phase 2 (completion + strong data) through regulatory engagement and into pivotal escalation, with clear runway through 2028.
This setup creates an optimal window to pursue BTD (on top of existing 08/2025 Fast Track ) during the funded @US_FDA meeting prep phase, maximizing speed toward approval in platinum-resistant ovarian cancer.
BTD approval is 60 days ⏳⌛️🚀
Phase2 each treatment 28 days cycle.. do they have prep-data and that’s how 20M$ was approved ?
Who would agree to take 20M$ and just sit and wait with NO DATA and PLAN in MOTION…?
Any suggestions @BioValues@IAmBiotech@IAmBiotech@BPharmCatalyst@ESGO_society@myESMO@PSOGI_EC@IJGConline@ENYGO_official@AJOG_thegray@gynoncjnls@oncodaily@JCO_ASCO@oncodaily@AmgenOncology@OncoAlert@bioAffinity
$GDC let’s have some fun example: so they dilute and got 100M$ and buy more $BTC with 64K that’s about 1,500 and 7,500 already own= 9,000 $BTC ���
Now for some strange unknown reason they actually have 1B shares.. (even thought there was only 1.5B total volume in entire May) 9,000BTC/1B-OS.
1BTC=111k shares. 🤷🤒🤪
111k shares x0.1$= 12K$ for 1-BTC
Crazy…. Not really… no one really counts BTC value with any current valuation…!
$HUBC diluted from 1.5M to 66M
About 64M shares. 30-days total volume is about 4,000 M
Price was everywhere 0.1-0.9-0.2-0.3$
With NO REAL cash/BTC assets..!
$GDC doesn’t have this type of swing nor volume…!
Total 30-day volume 1,500M And even if they dilute similar 64M shares… 😅🤷.
That will put total of 130M shares
7,500 $BTC 600M + 50M atm :) .
650$/130M=$5 per share..
Currently at 0.1$ 🤷
Hope that helps.
$HUBC diluted from 1.5M to 66M
About 64M shares. 30-days total volume is about 4,000 M
Price was everywhere 0.1-0.9-0.2-0.3$
With NO REAL cash/BTC assets..!
$GDC doesn’t have this type of swing nor volume…!
Total 30-day volume 1,500M And even if they dilute similar 64M shares… 😅🤷.
That will put total of 130M shares
7,500 $BTC 600M + 50M atm :) .
650$/130M=$5 per share..
Currently at 0.1$ 🤷
Hope that helps.
@Tony_Denaro U not including 5/21/26 Termination of Amendment (under NRS 78.390). Only talking about Restructure 5/13. (10B….? Yet at that time there was about 1B total volume!)
📣📣SPIRIT AIRLINES BONDHOLDERS CITADEL SECURITIES HOLDING EMPLOYEES FINAL PAYCHECKS 🪳🪳🪳
Another bad look for Ken Griffin Citadel Securities.
Class action lawsuits filed for
17 THOUSAND employees to receive their final paycheck and benefits.
Citadel Securities triggered the airlines collapse because they would make more money liquidating it's assets.
No concern for the 17,000 employees and their families.
$ALLR to put it all together in one place:
this is an open-label trial. management sees the patient data as it comes in. in real time. they are not guessing about what the results look like.
with that context - they voluntarily took on $20M in non-convertible debt. no warrants. no equity kicker. a debt-free company that chose structured debt with a hard maturity cliff over the easy path of selling a few million shares quietly into the market.
they ran two consecutive $5M buyback programs back to back. spent $3.45M buying their own stock. while carrying that debt.
the VA -which had access to approved PARP inhibitors -switched their trial to stenoparib and fully funded it. the FDA granted Fast Track months later. two independent institutions reached the same conclusion.
and now cohort 2 is enrolling with healthier patients and a higher dose arm than the one that already produced 22-month median overall survival(& some over 35 months) in a population where median survival without treatment is 3 to 6 months.
every single one of these decisions was made by people who can see the data. the loan structure, the buybacks, the refused equity options, the Lonza manufacturing contract - none of this is the behavior of a management team that is uncertain about what is coming.
$25M market cap. trading at a small premium to cash. interim data readout approximately 3 months away.
@mellgippson Yep, They don’t need us. I’m really not talking to any fuck out there or company. Just to normal retail shareholders and expressing my opinions and findings as they develop…